L M D Delbridge - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L M D Delbridge

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Molecular and Cellular Cardiology|May 11, 2007

The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivoR H Ritchie, J M Quinn, A H Cao, et al.

Journal of Molecular and Cellular Cardiology|January 15, 2008

Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate interventionC E Huggins, A A Domenighetti, M E Ritchie, et al.

Frontiers in Pharmacology|July 16, 2021

Fructose Metabolism and Cardiac Metabolic StressM Annandale, L J Daniels, X Li, et al.

Scientific Reports|July 31, 2023

Myocardial deformation imaging by 2D speckle tracking echocardiography for assessment of diastolic dysfunction in murine cardiopathologyL J Daniels, C Macindoe, P Koutsifeli, et al.

Biorxiv : the Preprint Server for Biology|October 3, 2025

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissuesK M Mellor, U Varma, P Koutsifeli, et al.

Nature Cardiovascular Research|September 30, 2025

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissuesK M Mellor, U Varma, P Koutsifeli, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Molecular and Cellular Cardiology|May 11, 2007

The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivoR H Ritchie, J M Quinn, A H Cao, et al.

Journal of Molecular and Cellular Cardiology|January 15, 2008

Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate interventionC E Huggins, A A Domenighetti, M E Ritchie, et al.

Frontiers in Pharmacology|July 16, 2021

Fructose Metabolism and Cardiac Metabolic StressM Annandale, L J Daniels, X Li, et al.

Scientific Reports|July 31, 2023

Myocardial deformation imaging by 2D speckle tracking echocardiography for assessment of diastolic dysfunction in murine cardiopathologyL J Daniels, C Macindoe, P Koutsifeli, et al.

Biorxiv : the Preprint Server for Biology|October 3, 2025

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissuesK M Mellor, U Varma, P Koutsifeli, et al.

Nature Cardiovascular Research|September 30, 2025

Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissuesK M Mellor, U Varma, P Koutsifeli, et al.

Pageof 2